ListenMinnesota doctor says FDA weight-loss drug cutoff is ‘devastating’ for patients
The amount of weight loss drugs on the market is about to shrink dramatically and cut thousands of Americans off from cheaper obesity drugs as the FDA halts the sale of copycats.
Companies and pharmacies were able to sell a cheaper alternative to the weight loss drug Wegovy and Ozempic because of a shortage of a protein called semaglutide, which helps regulate appetite…